A pericardioperitoneal shunt may be an effective long-term treatment option for refractory non-malignant pericardial effusion.
Answers are grounded in this paper and cite their sources.
May offer a durable option for refractory non-malignant effusions; leaves open need for prospective validation before wider use.
We report the case of a 74-year-old man treated for refractory non-malignant pericardial effusion using a pericardioperitoneal shunt. After the failure of conventional pericardiocentesis, a pericardioperitoneal shunt using a Denver shunt was inserted to drain the pericardial effusion into the peritoneal cavity. At 3-year follow-up, the effusion was well controlled and the shunt remained patent.
No takes yet. Share an insight, caveat, or question.
Ishida et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: